Rare disease status update: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Reviewer name}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Reviewer name}}
|-
|-
| rowspan="999" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | Rare disease
| rowspan="998" |Rare disease
| style="padding: 5px 5px; background: #F5F5F5;" | Aarskog Syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Abetalipoproteinemia
| style="padding: 5px 5px; background: #F5F5F5;" |Abetalipoproteinemia
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
Line 121: Line 113:
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Acquired Hemophilia
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
Line 129: Line 121:
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Acquired Lipodystrophy
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
Line 137: Line 129:
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Acquired Neuromyotonia
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
Line 145: Line 137:
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Acrocallosal Syndrome, Schinzel Type
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
Line 153: Line 145:
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Acrodermatitis Enteropathica
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
Line 161: Line 153:
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Acrodysostosis
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
Line 169: Line 161:
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Acromesomelic Dysplasia
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
Line 369: Line 361:
| style="padding: 5px 5px; background: #F5F5F5;" | Bernard-Soulier Syndrome
| style="padding: 5px 5px; background: #F5F5F5;" | Bernard-Soulier Syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
Line 377: Line 369:
| style="padding: 5px 5px; background: #F5F5F5;" |Blue Rubber Bleb Nevus syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Blue Rubber Bleb Nevus syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
Line 385: Line 377:
| style="padding: 5px 5px; background: #F5F5F5;" |Hairy Cell Leukemia
| style="padding: 5px 5px; background: #F5F5F5;" |Hairy Cell Leukemia
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
Line 393: Line 385:
| style="padding: 5px 5px; background: #F5F5F5;" |Hutchinson-Gilford Progeria
| style="padding: 5px 5px; background: #F5F5F5;" |Hutchinson-Gilford Progeria
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
Line 401: Line 393:
| style="padding: 5px 5px; background: #F5F5F5;" |Joubert Syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Joubert Syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
Line 409: Line 401:
| style="padding: 5px 5px; background: #F5F5F5;" |Merkel Cell Carcinoma
| style="padding: 5px 5px; background: #F5F5F5;" |Merkel Cell Carcinoma
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
Line 417: Line 409:
| style="padding: 5px 5px; background: #F5F5F5;" |Timothy Syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Timothy Syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
Line 425: Line 417:
| style="padding: 5px 5px; background: #F5F5F5;" |Wyburn-Mason Syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Wyburn-Mason Syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
Line 433: Line 425:
| style="padding: 5px 5px; background: #F5F5F5;" |Romano-Ward syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Romano-Ward syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
Line 441: Line 433:
| style="padding: 5px 5px; background: #F5F5F5;" |Jervell and Lange-Nielsen syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Jervell and Lange-Nielsen syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
Line 449: Line 441:
| style="padding: 5px 5px; background: #F5F5F5;" |Timothy syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Timothy syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
Line 457: Line 449:
| style="padding: 5px 5px; background: #F5F5F5;" |Andersen-Tawil syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Andersen-Tawil syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
Line 463: Line 455:
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Ameloblastoma
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Fahimeh
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Aarskog-Scott syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna Gunnam
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  

Revision as of 20:40, 7 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

System Leader: Vamsikrishna Gunnam M.B.B.S [3]

List of Chapters Requiring Content

Category Chapters that need content Assignment status Scholar name Coach name Completion status Review status Reviewer name
Rare disease Abetalipoproteinemia
Ablepharon-Macrostomia Syndrome
Acanthocheilonemiasis
Acanthosis Nigricans
Aceruloplasminemia
Acid Sphingomyelinase Deficiency
Achard Thiers Syndrome
Achondrogenesis
Achondroplasia
Acidemia Isovaleric
Acidemia, Methylmalonic
Acquired Aplastic Anemia
Acquired Hemophilia
Acquired Lipodystrophy
Acquired Neuromyotonia
Acrocallosal Syndrome, Schinzel Type
Acrodermatitis Enteropathica
Acrodysostosis
Acromesomelic Dysplasia

In-Progress Chapters

Category Chapters that need content Assignment status Scholar name Coach name Completion status Review status Reviewer name
Rare disease SIDS Assigned Krishna

Completed Chapters

Category Chapters that need content Assignment status Scholar name Coach name Completion status Review status Reviewer name
Rare disease Bernard-Soulier Syndrome Krishna Gunnam Completed Done Farima
Blue Rubber Bleb Nevus syndrome Krishna Gunnam Completed Done Anmol
Hairy Cell Leukemia Krishna Gunnam Completed
Hutchinson-Gilford Progeria Krishna Gunnam Completed
Joubert Syndrome Krishna Gunnam Completed
Merkel Cell Carcinoma Krishna Gunnam Completed
Timothy Syndrome Krishna Gunnam Completed Done Mahshid mir
Wyburn-Mason Syndrome Krishna Gunnam Completed
Romano-Ward syndrome Krishna Gunnam Completed
Jervell and Lange-Nielsen syndrome Krishna Gunnam Completed
Timothy syndrome Krishna Gunnam Completed
Andersen-Tawil syndrome Krishna Gunnam Completed
Ameloblastoma Krishna Gunnam Completed Done Fahimeh
Aarskog-Scott syndrome Krishna Gunnam Completed